Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Rang in Aktien #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Aktienkurs
$11.03
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$597.15M
Veränderung (1 Tag)
-4.25%
Veränderung (1 Jahr)
-
Land
US
Handel Eikon Therapeutics, Inc. Common Stock (EIKN)

Kategorie

Aktien-Split-Historie für Eikon Therapeutics, Inc. Common Stock (EIKN)
Die Aktie Eikon Therapeutics, Inc. Common Stock (Symbol: EIKN) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 31, 2026 statt.
Eine EIKN-Aktie, die vor dem Aug 31, 2026 gekauft wurde, entspricht heute 0 EIKN-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH